Mineralys Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -13 | -15 | -16 | -15 |
EBITDA | -38,267 | -36,917 | -46,730 | -44,432 |
EBIT | -38,280 | -36,932 | -46,746 | -44,447 |
Net Income | -32,234 | -36,932 | -43,274 | -42,211 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -37,903 | -28,872 | -30,169 | -45,487 |
Cash | 172,921 | 217,597 | 101,788 | 165,007 |
Basic Shares | 80,545 | 70,594 | 65,451 | 53,163 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -59 | -43 | ||
EBITDA | -170,604 | -192,360 | -84,657 | -31,479 |
EBIT | -170,663 | -192,403 | -84,824 | -31,479 |
Net Income | -154,651 | -177,810 | -71,898 | -29,799 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -142,431 | -166,410 | -81,173 | -29,221 |
Cash | 172,921 | 114,091 | 49,304 | 87,701 |
Basic Shares | 67,656 | 48,539 | 36,188 | 5,167 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.40 |
2025-09-30 | -$0.52 |
2025-06-30 | -$0.66 |
